I would be curious as to why CTSO's "next generation" product would now advertise "endotoxin removal" as the key change/advancement?

Seems odd, do they want their share to plummet to 20 cents?

What do their medical advisers know about ENDOTOXIN?  they have our DSMB member on board and one of the globe's top nephrologists and friend to both Spectral and Toraymyxin?

Makes you go HUH??????

CytoSorb-XL is a new, state-of-the-art porous polymer bead technology that combines lipopolysaccharide (LPS) endotoxin removal with the robust cytokine, toxin, and inflammatory mediator reduction achieved by CytoSorb®.  CytoSorb-XL and its novel endotoxin binding chemistry is the subject of a broad composition of matter patent application, intended to protect the technology worldwide for the next two decades.